Holen Sie sich die Stockscreener-App
261.61
3.46%
-9.39
Handel nachbörslich:
261.90
0.29
+0.11%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HUM?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$271.00
Offen:
$266.115
24-Stunden-Volumen:
2.75M
Relative Volume:
1.42
Marktkapitalisierung:
$31.46B
Einnahmen:
$123.11B
Nettoeinkommen (Verlust:
$1.58B
KGV:
20.08
EPS:
13.0294
Netto-Cashflow:
$2.44B
1W Leistung:
-11.39%
1M Leistung:
-5.36%
6M Leistung:
-8.15%
1J Leistung:
-2.24%
1-Tages-Spanne:
$257.94
$268.00
1-Wochen-Bereich:
$257.94
$302.79
52-Wochen-Spanne:
$206.87
$315.35
Humana Inc Stock (HUM) Company Profile
Firmenname
Humana Inc
Sektor
Branche
Telefon
(502) 580-1000
Adresse
500 W MAIN ST, LOUISVILLE, KY
Vergleichen Sie HUM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
261.61 | 32.59B | 123.11B | 1.58B | 2.44B | 13.03 |
|
UNH
Unitedhealth Group Inc
|
359.93 | 324.83B | 422.82B | 22.09B | 25.27B | 23.09 |
|
CVS
Cvs Health Corp
|
79.66 | 99.49B | 386.46B | 4.49B | 4.78B | 3.5841 |
|
CI
Cigna Group
|
302.13 | 78.85B | 261.22B | 5.40B | 3.94B | 18.31 |
|
ELV
Elevance Health Inc
|
350.48 | 79.13B | 189.25B | 5.35B | 5.34B | 23.49 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-22 | Eingeleitet | Evercore ISI | In-line |
| 2025-05-01 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-10-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-03-22 | Eingeleitet | Raymond James | Mkt Perform |
| 2024-03-13 | Herabstufung | Argus | Buy → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Hochstufung | Argus | Hold → Buy |
| 2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Herabstufung | Argus | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-04-13 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-04 | Bestätigt | Barclays | Overweight |
| 2021-11-04 | Bestätigt | Credit Suisse | Outperform |
| 2021-11-04 | Bestätigt | Morgan Stanley | Overweight |
| 2021-11-04 | Bestätigt | Oppenheimer | Outperform |
| 2021-11-04 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-09-09 | Fortgesetzt | Barclays | Overweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-01-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-16 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-01-03 | Bestätigt | JP Morgan | Overweight |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Bestätigt | BofA/Merrill | Buy |
| 2018-09-13 | Eingeleitet | Barclays | Overweight |
| 2018-07-12 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-07-06 | Bestätigt | Piper Jaffray | Overweight |
| 2018-06-01 | Fortgesetzt | Citigroup | Buy |
| 2018-02-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-12 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Humana Inc Aktie (HUM) Neueste Nachrichten
Humana Stock Slumps After Reportedly Losing Lawsuit Seeking To Undo Cuts To Medicare Bonus Payments - Stocktwits
Humana loses challenge to 2025 Medicare Advantage ratings - MSN
Why Humana (HUM) Shares Are Sliding Today - FinancialContent
Humana loses challenge to 2025 Medicare Advantage ratings By Reuters - Investing.com
Humana loses Medicare Advantage star ratings lawsuit - Modern Healthcare
Humana slips after losing lawsuit to reverse Medicare Star ratings - TradingView
Humana Loses Second Lawsuit to Reverse Medicare Bonus Cuts - Bloomberg.com
Humana Foundation targets better senior emotional health with expanded grant effort - Lane Report
Humana rebuffed by federal court in challenge over Medicare plan Star Ratings ( - Seeking Alpha
Humana stock falls after losing Medicare bonus lawsuit, Goldman sell rating - Investing.com
Humana hosting pickleball pop-up at Woodfield Mall Saturday - Daily Herald
Humana Foundation Expands National Efforts to Improve Seniors’ Emotional Health – Company Announcement - Financial Times
Humana price exposed to negative pressureForecast today14-10-2025 - Economies.com
Can Humana Inc. stock deliver strong Q4 earningsQuarterly Investment Review & Weekly Watchlist of Top Performers - newser.com
Humana (HUM) Stock Signal 14/10: Is More Downside Ahead? - DailyForex
How institutional ownership impacts Humana Inc. stock2025 Market Overview & Weekly High Return Opportunities - newser.com
What MACD signals say about Humana Inc.Trade Volume Report & Safe Entry Zone Identification - newser.com
Why Humana Inc. stock is a must watch in 2025July 2025 Price Swings & Reliable Momentum Entry Alerts - newser.com
Is Humana Inc. stock poised for growthMarket Activity Report & Low Risk Profit Maximizing Plans - newser.com
Hospital dropping Humana Medicare Advantage; offers patient resources - Montrose Daily Press
Concerns rise over Mercy Health / Humana negotiations - WKBN.com
Jim Cramer: Humana (HUM) Keeps Rising – A “Totally Independent” Healthcare Stock - MSN
How Humana Inc. stock performs in stagflationMarket Weekly Review & Daily Risk Controlled Trade Plans - newser.com
Humana Inc. stock outlook for YEAR2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - newser.com
Women CFOs Outperform. Here’s How Humana And Merck Prove It. - Forbes
Using economic indicators to assess Humana Inc. potentialJuly 2025 Summary & Comprehensive Market Scan Reports - newser.com
Humana : Invitation to presentation of Humana's report on third quarter 2025 - MarketScreener
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, - GlobeNewswire
How to escape a deep drawdown in Humana Inc.Trade Entry Summary & Precise Buy Zone Identification - newser.com
Humana Inc. $HUM is Pzena Investment Management LLC's 10th Largest Position - MarketBeat
Leith Wheeler Investment Counsel Ltd. Raises Holdings in Humana Inc. $HUM - MarketBeat
Truist Financial Corp Sells 2,231 Shares of Humana Inc. $HUM - MarketBeat
Allspring Global Investments Holdings LLC Reduces Stock Holdings in Humana Inc. $HUM - MarketBeat
US Bancorp DE Has $7.76 Million Holdings in Humana Inc. $HUM - MarketBeat
Can Humana Inc. stock sustain market leadershipWeekly Trade Recap & Fast Moving Market Watchlists - newser.com
Will Humana Inc. stock deliver shareholder valueMarket Trend Report & Trade Opportunity Analysis - newser.com
Is Humana Inc. stock oversold or undervaluedGDP Growth & Fast Gain Stock Trading Tips - newser.com
What makes Humana Inc. stock attractive to growth funds2025 Momentum Check & Smart Swing Trading Techniques - newser.com
Sivik Global Healthcare LLC Buys 4,000 Shares of Humana Inc. $HUM - MarketBeat
How Humana Inc. (HUM) stock benefits from digital adoptionQuarterly Performance Summary & Daily Volume Surge Signals - newser.com
Humana (NYSE:HUM) Price Target Raised to $300.00 at Bank of America - MarketBeat
Is Humana a Bargain After Recent Stock Slide and Mixed Performance in 2025? - Yahoo Finance
Court Orders Humana to Pay $90M in Groundbreaking Whistleblower Medicare Fraud Case Settlement - Healthcare Innovation
Humana pulls Part D plans from brokerage portals - Modern Healthcare
How Humana’s (HUM) Medicare Advantage Enrollment Surge and Guidance Reaffirmation Shape Its Investment Case - simplywall.st
Humana Inc. to Release Third Quarter 2025 Results on November 5, 2025 - FinancialContent
Humana (HUM) Receives Maintained Rating and Raised Price Target from B of A Securities | HUM Stock News - GuruFocus
Humana’s Patrick Nugent applies his extensive broker experience to deliver superior employee benefits across the Chicago region - The Business Journals
Humana’s Mitch Kumagai on why smarter, healthier benefits matter for Bay Area businesses and employees - The Business Journals
2026 MA Star Ratings: Aetna, Humana see scores decline; UnitedHealthcare improves - Fierce Healthcare
Winners and losers from 2026 Medicare Advantage star ratings - Healthcare Dive
Finanzdaten der Humana Inc-Aktie (HUM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.22%
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):